Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Akston Biosciences Strengthens Board with Addition of John T. Preston
Akston Biosciences Corporation, a clinical-stage biotechnology company, today announced that John Preston, a founder of […]
Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors
Gandeeva Therapeutics, a biotechnology company focused on designing and developing precision therapeutics guided by cryogenic […]
Relmada Therapeutics Appoints Fabiana Fedeli from M&G Investments to its Board of Directors
Relmada Therapeutics, a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today […]
Quanterix Announces Appointment of Brian Blaser to Board of Directors
Quanterix Corporation, a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it […]
SoniVie Raises $60m in Round C Financing and Appoints New Board Members
SoniVie, a medical device company developing a proprietary solution to treat hypertension, announced today the […]
Pneumagen Appoints James Noble, a Highly Experienced Biotech Leader, as Chairman of its Board of Directors
Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal drug for the […]
NHS England Appoints Leading Clinicians To Board
NHS England has added a wealth of clinical expertise and experience to its board with […]
NMD Pharma Appoints Mike Heffernan as Chairman of Board of Directors
NMD Pharma A/S, a clinical-stage biotech company developing first-in-class, small molecule ClC-1 inhibitors for neuromuscular […]
Mestag Therapeutics Appoints Professor Ton Logtenberg as Chair
Mestag Therapeutics, an immunotherapy company harnessing new insights into fibroblast-immune interactions in cancer and inflammatory […]
Eiger BioPharmaceuticals Announces Leadership Change
Eiger BioPharmaceuticals, a commercial-stage biopharmaceutical company focused on the development of innovative therapies for hepatitis […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more